글락소스미스클라인(GSK)는 NYSE에 상장된 Healthcare · Drug Manufacturers - General 기업입니다. 현재가 $50.22 (-1.65%), 시가총액 $101.38B, PER (주가수익비율) 13.08, 52주 최저~최고 $36.20 ~ $61.18.
GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through Commercial Operations and Total R&D segments. The company offers specialty medicines that include oncology, respiratory/immunology, inflammation, and inhaled medicines for HIV, respiratory eosinophildriven diseases, lupus and lupus nephritis, ovarian cancer, and endometrial cancer. It also provides vaccines for Shingles, Meningitis, RSV, Seasonal Influenza, Hepatitis, Diphtheria, Tetanus, Acellular Pertussis, Rotavirus, Pertussis, Po
글락소스미스클라인의 재무제표, 목표주가, 기관투자자(13F) 보유 현황, 관련 뉴스는 BlackAll Trade에서 실시간으로 확인할 수 있습니다.
글락소스미스클라인의 현재 주가는 $50.22 (-1.65%)입니다. BlackAll Trade에서 실시간 시세와 차트를 확인할 수 있습니다.
글락소스미스클라인의 시가총액은 약 $101.38B입니다. PER은 13.08입니다.
GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdo